Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy.
Main Authors: | Wei Du, Yong Yi, Haibo Zhang, Johann Bergholz, Junfeng Wu, Haoqiang Ying, Yujun Zhang, Zhi-Xiong Jim Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3866301 |
Similar Items
-
Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy.
by: Wei Du, et al.
Published: (2013-01-01) -
Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
by: Wei Du, et al.
Published: (2013-01-01) -
Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53
by: Xin Tian, et al.
Published: (2016-10-01) -
Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway.
by: Lei Liu, et al.
Published: (2010-05-01) -
STAT1, IGF1, RAC1, and MDM2 Are Associated with Recurrence of Giant Cell Tumor of Bone
by: Shuxin Chen, et al.
Published: (2018-01-01)